Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Amazon sued over 'punitive' handling of employee absences - 2The Most Vital Crossroads in Olympic History
- 3Hundreds of Gazans evacuated from Strip for medical treatment - COGAT
- 4Knesset FADC extends emergency draft for 280,000 IDF reservists until January 1
- 5Why most Jewish Israelis back the death penalty for terrorists
- Instructions to Warmly greet Certainty and Appeal
- WHO issues guidance on GLP-1 drugs for obesity
- Russia Establishing Long-Range Drone Bases In Belarus, Warns Ukraine
- Grasping the Elements of Medical caretaker Pay rates: Factors That Shape Your Pay
- Figure out How to Explore the Infotainment Framework in the Slam 1500.
- Most loved Seared Chicken: Which Chain Rules?
- New law puts familiar drinks, creams and gummies in legal limbo
- Social Skylines d: A Survey of \Inside and out Social Experiences\ Language Learning Book
- See the famous winged horse Pegasus fly in the autumn night sky
